Federico Grossi - 06 Jan 2025 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Reporting relationship: Chief Medical Officer
Issuer ticker: UBX
Reported as of: 06 Jan 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jan 2025, 16:35:03 UTC
Prior SEC filing: 07 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Alexander Nguyen, Attorney-in-Fact for Federico Grossi

Key filing fact

Federico Grossi filed Form 4 for Unity Biotechnology, Inc. (UBX) on 07 Jan 2025.

Key facts

This page summarizes Federico Grossi's Form 4 filing for Unity Biotechnology, Inc. (UBX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Jan 2025, 16:35.

Change

Previous filing in this sequence was filed on 07 Jan 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UBX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +150,000
Change %
Price: $0.000000
Shares after: 150,000
Date: 06 Jan 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 150,000
Exercise price: $1.78
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The underlying shares vest and become exercisable pursuant to the following schedule: 1/48th of the shares subject to the option vest in successive, equal monthly installments on each monthly anniversary of the Vesting Commencement Date of January 1, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.